4 Recruiting Resectable Hepatocellular Carcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Recruiting Resectable Hepatocellular Carcinoma Studies
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
SIRT With Tremelimumab and Durvalumab for Resectable HCC
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer
📍 Houston Methodist Hospital — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔ 🟡 Not Yet Recruiting Early Phase1 💊 Investigational Drug / Biologic
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
📍 University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔